ResMed Inc. is a leading global medical technology enterprise engaged in the creation, production, distribution, and marketing of healthcare devices and connected digital solutions. The company operates through two primary segments: Sleep and Respiratory Care, and Software as a Service. Its extensive product range addresses a variety of respiratory disorders, encompassing advanced medical and consumer technologies, ventilation devices, diagnostic equipment, mask systems for both clinical and personal use, headgear, and related accessories, alongside dental devices. ResMed also provides…
| Price | $226.58 |
|---|---|
| Market cap | $32.87B |
| Sector | Healthcare |
| Industry | Medical - Instruments & Supplies |
| Exchange | NYSE |
| 52-week range | 180.27-284.87 |
| Dividend (TTM) | $2.46 per share |
| Beta | 0.77 |
Explore RMD's full valuation scorecard, price history, financial statements, insider and institutional ownership, and peer comparison on this page — free, no login required.